News: Agilex Biolabs Accelerates Client Portal Launch to Enhance Study Information Access and Communications During COVID-19
Agilex Biolabs, Australia’s most advanced FDA-inspected specialist bioanalytical laboratory for clinical trials, has brought forward implementation of the Agilex Client Portal in response to the continued global COVID-19 outbreak and increased client demand for the Australian biolab.
13th EBF Poster Presentation
Development and Validation of a PK Method for Tocilizumab in Both Singlicate and Duplicate on the Gyrolab Platform
Client News: Agilex Biolabs Client Shasqi Announces Click Chemistry Breakthrough with First-Ever Human Application in Launch of Clinical Program
Agilex Biolabs, Australia’s most advanced FDA-inspected specialist bioanalytical laboratory for clinical trials, congratulates client company Shasqi on the announcement of the first-ever application of click chemistry in humans, with the launch of the Company’s lead clinical candidate, SQ3370. Shasqi is the first Y Combinator-backed biotech company to reach clinical development.
Client News: Agilex Biolabs Congratulates Bioanalytics Client Zelira Therapeutics on Successful Phase 2 Medicinal Cannabis Insomnia Study
Agilex Biolabs, Australia’s most advanced specialist bioanalytical laboratory for clinical trials, congratulated client Zelira Therapeutics on their Phase 2 Medicinal Cannabis Insomnia Study.
Agilex Biolabs Develops World’s Most Accurate Cannabinoid Assay
Award-winning Agilex Biolabs, the Asia-Pacific region’s leading bioanalytical laboratory for clinical trials, based in Australia, has developed the world’s most accurate cannabinoid assay.
Agilex Biolabs and Endpoints News Present ‘How to Move Trials to Australia’ Webinar
Agilex Biolabs, Australia’s largest specialist bioanalytical laboratory for clinical trials, and Endpoints News launched a new webinar “How Easy is it to Move Your Trials to Australia” at BIO Taiwan 2020 (watch here).
Agilex Biolabs Encourages Biotechs to Move Delayed Trials to Australia at BIO Digital 2020
Adelaide, Australia – Agilex Biolabs, Australia’s largest specialist bioanalytical laboratory for clinical trials, encouraged biotechs to consider Australia for their clinical trials during a presentation at BIO Digital 2020.
Australia’s impressive COVID-19 management and the world’s most attractive rebate on clinical trials costs are just a few of the reasons that make it an ideal location to restart delayed trials, according to Agilex Biolabs.
Transcript | Endpoints Webinar
Arsalan Arif: All right. Hi everybody. I'm Arsalan Arif, the publisher of Endpoints News and I'm pleased to be your moderator today. Today's webinar is sponsored by Agilex Biolabs in Australia and our topic is the Australian Advantage, de-risk your early phase trials....
Endpoints New webinar: featuring Agilex Biolabs Dr Kurt Sales.
Agilex Biolabs at BIO Korea – Dr Kurt Sales presents the Australian Advantage
https://youtu.be/sCUT8qtlRX4?t=4454
Talk to us about your next project
We bring in our client services and scientific experts to offer you the best solutions Contact UsOr book a call with us nowPlease fill in this form and we will be in contact shortly: